Fox Run Management L.L.C. Invests $1.18 Million in Waters Corporation $WAT

Fox Run Management L.L.C. bought a new position in Waters Corporation (NYSE:WAT) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,116 shares of the medical instruments supplier’s stock, valued at approximately $1,184,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. ANTIPODES PARTNERS Ltd bought a new position in Waters in the 3rd quarter valued at approximately $26,000. Hantz Financial Services Inc. raised its holdings in Waters by 115.4% in the 3rd quarter. Hantz Financial Services Inc. now owns 112 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 60 shares during the last quarter. eCIO Inc. bought a new position in Waters in the 4th quarter valued at approximately $49,000. Annis Gardner Whiting Capital Advisors LLC raised its holdings in Waters by 28.3% in the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 163 shares of the medical instruments supplier’s stock valued at $62,000 after buying an additional 36 shares during the last quarter. Finally, MUFG Securities EMEA plc bought a new position in Waters in the 2nd quarter valued at approximately $61,000. Institutional investors own 94.01% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently issued reports on WAT shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Waters in a report on Monday, April 20th. UBS Group raised their price objective on shares of Waters from $330.00 to $375.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Citigroup started coverage on shares of Waters in a report on Tuesday, February 10th. They issued a “buy” rating and a $425.00 price objective for the company. JPMorgan Chase & Co. raised their price objective on shares of Waters from $330.00 to $345.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Finally, Wells Fargo & Company raised their price objective on shares of Waters from $355.00 to $370.00 and gave the company an “equal weight” rating in a report on Thursday, May 14th. Three investment analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $394.24.

Waters Stock Performance

NYSE:WAT opened at $371.45 on Wednesday. The company has a market capitalization of $36.47 billion, a PE ratio of 47.20, a P/E/G ratio of 2.20 and a beta of 1.21. The company has a 50 day simple moving average of $333.93 and a two-hundred day simple moving average of $350.57. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.13 and a current ratio of 1.79. Waters Corporation has a fifty-two week low of $275.05 and a fifty-two week high of $414.15.

Waters (NYSE:WAT) last released its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share for the quarter, beating analysts’ consensus estimates of $2.31 by $0.39. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.20 billion. Waters had a net margin of 11.91% and a return on equity of 15.60%. The company’s revenue for the quarter was up 91.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.25 EPS. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. Research analysts anticipate that Waters Corporation will post 14.5 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Wei Jiang bought 500 shares of the firm’s stock in a transaction on Monday, March 16th. The stock was acquired at an average price of $289.46 per share, with a total value of $144,730.00. Following the transaction, the director owned 3,441 shares of the company’s stock, valued at $996,031.86. This trade represents a 17.00% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.31% of the company’s stock.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.